Market Overview

Syneos Health Shares Down 2.5% Following Q1 Beat, Guidance; Baird Highlights Belief Market Is 'Dead Wrong' On Stock, Says Shares Could Hit $45-$50 Range By Q2 Print


This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.

Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.

Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real-time — before the crowd.

Start your FREE 14-day trial of Benzinga Pro today.

Latest Ratings for SYNH

Sep 2019MaintainsOverweight
Aug 2019MaintainsNeutral
Aug 2019MaintainsOutperform

View More Analyst Ratings for SYNH
View the Latest Analyst Ratings

Posted-In: Analyst Color Earnings News Guidance Analyst Ratings Movers Trading Ideas


Related Articles (SYNH)

How AI And Blockchain Are Transforming The Way We Invest

A Multi-Factor ETF Is Coming Of Age